ATE433462T1 - Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden - Google Patents

Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden

Info

Publication number
ATE433462T1
ATE433462T1 AT05254121T AT05254121T ATE433462T1 AT E433462 T1 ATE433462 T1 AT E433462T1 AT 05254121 T AT05254121 T AT 05254121T AT 05254121 T AT05254121 T AT 05254121T AT E433462 T1 ATE433462 T1 AT E433462T1
Authority
AT
Austria
Prior art keywords
endometriosis
epp2
serum
react
human protein
Prior art date
Application number
AT05254121T
Other languages
German (de)
English (en)
Inventor
El Shami A Said
Bruce Campbell
Dennis Sustarsic
Niver Sahakian
Original Assignee
Siemens Healthcare Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics filed Critical Siemens Healthcare Diagnostics
Application granted granted Critical
Publication of ATE433462T1 publication Critical patent/ATE433462T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
AT05254121T 2004-07-07 2005-06-30 Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden ATE433462T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/887,540 US20060008876A1 (en) 2004-07-07 2004-07-07 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis

Publications (1)

Publication Number Publication Date
ATE433462T1 true ATE433462T1 (de) 2009-06-15

Family

ID=35124497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05254121T ATE433462T1 (de) 2004-07-07 2005-06-30 Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden

Country Status (9)

Country Link
US (7) US20060008876A1 (enExample)
EP (1) EP1614692B1 (enExample)
JP (1) JP2006051019A (enExample)
AT (1) ATE433462T1 (enExample)
AU (1) AU2005202925A1 (enExample)
CA (1) CA2509632A1 (enExample)
DE (1) DE602005014828D1 (enExample)
ES (1) ES2326324T3 (enExample)
NZ (1) NZ541063A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087152B1 (en) * 2006-10-27 2015-03-11 Walfish, Paul Endometrial biomarkers
US8279789B2 (en) * 2008-06-10 2012-10-02 Qualcomm Incorporated Intelligent setting of hysteresis activation timer to enter hysteresis sooner and save battery
US20110171291A1 (en) * 2010-01-07 2011-07-14 Sanford-Burnham Medical Research Institute Pathologically-activated therapeutics
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
GB202310300D0 (en) 2023-07-05 2023-08-16 Univ Edinburgh Endometrosis markers and methods of diagnosing nedometriosis

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US652187A (en) * 1899-11-02 1900-06-19 Sigvald Krohn System of electrical distribution.
US4489166A (en) * 1982-05-27 1984-12-18 Research Corporation Monitoring of human endometrial function by radioimmunoassay of PEP
NZ232801A (en) 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
ATE141278T1 (de) 1991-03-15 1996-08-15 Hoffmann La Roche Diphosphonsaurederivate als zwischenprodukte zur herstellung von diphosphinliganden
CA2062675A1 (en) 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
US5877284A (en) * 1993-08-12 1999-03-02 The Trustees Of The University Of Pennsylvania Isolated chemotactic factor from patients with endometriosis
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US6531277B2 (en) * 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US7122322B2 (en) * 1994-10-25 2006-10-17 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US6376201B2 (en) * 1994-12-28 2002-04-23 Procrea Biosciences Inc. Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
WO1997035016A1 (en) 1996-03-18 1997-09-25 Novo Nordisk Biotech Inc Polypeptides having phytase activity and nucleic acids encoding same
WO1997035018A1 (en) 1996-03-21 1997-09-25 New York University Growth factor inducible serine/threonine phosphatase fin13
US6294662B1 (en) * 1996-08-27 2001-09-25 University Of South Florida Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
JP2001516009A (ja) 1997-07-17 2001-09-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ ガン関連核酸及びポリペプチド
US6165767A (en) * 1998-03-20 2000-12-26 Incyte Pharmaceuticals, Inc. Protein phosphatase-related molecules
CA2299436A1 (en) 1998-06-04 1999-12-09 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
US6387629B1 (en) * 1998-06-04 2002-05-14 Reprogen, Inc. Use of cathepsin S in the diagnosis and treatment of endometriosis
US6525187B1 (en) * 1998-07-31 2003-02-25 Diagnostic Products Corporation Polynucleotide encoding autoantigens associated with endometriosis
ES2292424T3 (es) 1999-01-25 2008-03-16 Siemens Medical Solutions Diagnostics Metodo para dioagnosticar endometricos.
DE60008712D1 (de) * 1999-04-02 2004-04-08 Ct Molecular Med & Immunology Verfahren zur detektion von endometriosis
AU4233500A (en) 1999-04-16 2000-11-02 Bioincept, Inc. Identification of a serum marker for endometriosis
CA2375424A1 (en) * 1999-06-03 2000-12-14 Curagen Corporation Novel polynucleotides and polypeptides encoded thereby
WO2001032920A2 (en) 1999-11-03 2001-05-10 Metris Therapeutics Limited Agents implicated in endometriosis
GB0004232D0 (en) 2000-02-24 2000-04-12 Zeneca Ltd Diagnostic method
AU2001237178A1 (en) * 2000-02-25 2001-09-03 Metriogene Biosciences Inc. Endometriosis-related markers and uses thereof
WO2001079846A2 (en) * 2000-04-19 2001-10-25 Research Corporation Technologies, Inc. Diagnostic assay for endometriosis
US6645725B2 (en) * 2000-04-19 2003-11-11 Research Corporation Technologies, Inc. Diagnostic assay for endometriosis
US6780594B2 (en) * 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
DE10048633A1 (de) 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
AU2002255478A1 (en) 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
AU2002320630A1 (en) * 2001-07-17 2003-03-03 University Of Florida Detecting and treating reproductive tract disorders
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004087874A2 (en) 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6843673B1 (en) * 2004-04-30 2005-01-18 Speed Tech Corp. Coaxial connector structure

Also Published As

Publication number Publication date
US20070141600A1 (en) 2007-06-21
CA2509632A1 (en) 2006-01-07
US7981626B2 (en) 2011-07-19
US20110201129A1 (en) 2011-08-18
EP1614692A3 (en) 2006-04-05
US8030007B2 (en) 2011-10-04
NZ541063A (en) 2008-07-31
US7879562B2 (en) 2011-02-01
AU2005202925A1 (en) 2006-02-02
US20100330696A1 (en) 2010-12-30
JP2006051019A (ja) 2006-02-23
ES2326324T3 (es) 2009-10-07
US20080153106A1 (en) 2008-06-26
EP1614692B1 (en) 2009-06-10
US20070178528A1 (en) 2007-08-02
EP1614692A2 (en) 2006-01-11
US20100062453A1 (en) 2010-03-11
US20060008876A1 (en) 2006-01-12
DE602005014828D1 (de) 2009-07-23

Similar Documents

Publication Publication Date Title
Han et al. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
Vitale et al. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage
WO2005010048A3 (en) Rg1 antibodies and uses thereof
WO2003000853A3 (en) Protein aggregation assays and uses thereof
WO2001055393A3 (en) Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
US11193942B2 (en) Methods and devices for female health monitoring
EP1427744A4 (en) SYSTEM FOR ANTIBODY EXPRESSION AND SYNTHESIS
WO2010009987A3 (en) Diagnostic antibody assay
MX2010013692A (es) Deteccion de uso de cannabis.
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
EP4249511A3 (en) Anti-pd-l1/anti-lag3 bispecific antibodies and uses thereof
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
EP2287618A3 (en) Method for diagnosing neuro-degenerative disease
WO2009126969A3 (en) Biomarkers for endometrial disease
WO2004078938A3 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
DE602005014828D1 (de) ME-5, ME-2, and EPP2: menschliche Proteinantigene, die mit Autoantikörpern reagieren, die im Serum von Frauen vorliegen, die an Endometriose leiden
WO2007051169A3 (en) Use of b cell expansion agents in generating antibodies
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
Souček et al. Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma
WO2004018995A3 (en) Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents
AU6008800A (en) Preparation of spheres for diagnostic tests

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties